Quote | SILO Pharma Inc (OTCMKTS:SILO)
Last: | $0.17 |
---|---|
Change Percent: | -1.43% |
Open: | $0.1775 |
Close: | $0.17 |
High: | $0.18 |
Low: | $0.17 |
Volume: | 87,553 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | SILO Pharma Inc (OTCMKTS:SILO)
2024-04-25 08:13:17 ET Losers: Meta Platforms META -15% after Q1 earnings release . AGBA Group Holding Limited ( AGBA ) -13% . Marinemax HZO -11% after Q2 earnings release . Wimi Hologram Cloud ( WIMI ) -10% . International Business Mach...
2024-04-24 08:45:23 ET More on pre-market losers & stocks. ING: Still Too Cheap Despite Disappointing Results ING Groep NV (ING) Q4 2023 Earnings Call Transcript Palisade Bio stock rallies nearly 100% on colitis drug analysis Palisade Bio stock slides 8% ...
Message Board Posts | SILO Pharma Inc (OTCMKTS:SILO)
Subject | By | Source | When |
---|---|---|---|
$SILO gaining traction on news #PTSD #Anxiety | Garbage2Gucci | investorshub | 04/20/2023 3:07:36 PM |
NetworkNewsWire: Silo Pharma Inc. (NASDAQ: SILO) Provides Update on Innovative Study Looking into th | NetworkNewsWire | investorshangout | 03/28/2023 8:42:36 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fi | NetworkNewsWire | investorshangout | 03/27/2023 7:55:53 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Positioned as Frontrunner in Psy | NetworkNewsWire | investorshangout | 03/24/2023 9:08:31 PM |
NetworkNewsWire: NetworkNewsBreaks Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from | NetworkNewsWire | investorshangout | 03/15/2023 7:38:09 PM |
News, Short Squeeze, Breakout and More Instantly...
SILO Pharma Inc Company Name:
SILO Stock Symbol:
OTCMKTS Market:
Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive data in the final validation report from the recent pharm...
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing n...